Selected research
Industry Research
Potassium-Sparing Diuretic Industry Research Report 2026
Market perspective
The global Potassium-Sparing Diuretic market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Potassium-Sparing Diuretic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Potassium-Sparing Diuretic is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Potassium-Sparing Diuretic is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Potassium-Sparing Diuretic include Teva, Novartis, Merck, Pfizer, Bayer, Validus Pharmaceuticals, CMP Pharma, Centaur Pharmaceuticals and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Potassium-Sparing Diuretic market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Potassium-Sparing Diuretic Market by Company
Teva
Novartis
Merck
Pfizer
Bayer
Validus Pharmaceuticals
CMP Pharma
Centaur Pharmaceuticals
Boehringer Ingelheim
Amneal Pharmaceuticals
Accord Healthcare
Potassium-Sparing Diuretic Segment by Type
Amiloride
Triamterene
Spironolactone
Eplerenone
Others
Potassium-Sparing Diuretic Segment by Application
Heart Failure
Hypertension
Liver Cirrhosis
Edema
Others
Potassium-Sparing Diuretic Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Potassium-Sparing Diuretic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Potassium-Sparing Diuretic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Potassium-Sparing Diuretic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Potassium-Sparing Diuretic manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Potassium-Sparing Diuretic by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Potassium-Sparing Diuretic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Amiloride
- Triamterene
- Spironolactone
- Eplerenone
- Others
Applications
- Heart Failure
- Hypertension
- Liver Cirrhosis
- Edema
- Others
Companies covered
- Teva
- Novartis
- Merck
- Pfizer
- Bayer
- Validus Pharmaceuticals
- CMP Pharma
- Centaur Pharmaceuticals
- Boehringer Ingelheim
- Amneal Pharmaceuticals
- Accord Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Potassium-Sparing Diuretic Market Size (2021-2032)
- 2.2.2 Global Potassium-Sparing Diuretic Sales (2021-2032)
- 2.2.3 Global Potassium-Sparing Diuretic Market Average Price (2021-2032)
- 2.3 Potassium-Sparing Diuretic by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Amiloride
- 2.3.3 Triamterene
- 2.3.4 Spironolactone
- 2.3.5 Eplerenone
- 2.3.6 Others
- 2.4 Potassium-Sparing Diuretic by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Heart Failure
- 2.4.3 Hypertension
- 2.4.4 Liver Cirrhosis
- 2.4.5 Edema
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Potassium-Sparing Diuretic Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Potassium-Sparing Diuretic Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Potassium-Sparing Diuretic Revenue of Manufacturers (2021-2026)
- 3.4 Global Potassium-Sparing Diuretic Average Price by Manufacturers (2021-2026)
- 3.5 Global Potassium-Sparing Diuretic Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Potassium-Sparing Diuretic, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Potassium-Sparing Diuretic, Product Type & Application
- 3.8 Global Manufacturers of Potassium-Sparing Diuretic, Established Date
- 3.9 Global Potassium-Sparing Diuretic Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Potassium-Sparing Diuretic Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Potassium-Sparing Diuretic Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Potassium-Sparing Diuretic Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Potassium-Sparing Diuretic Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Bayer
- 4.5.1 Bayer Company Information
- 4.5.2 Bayer Business Overview
- 4.5.3 Bayer Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer Potassium-Sparing Diuretic Product Portfolio
- 4.5.5 Bayer Recent Developments
- 4.6 Validus Pharmaceuticals
- 4.6.1 Validus Pharmaceuticals Company Information
- 4.6.2 Validus Pharmaceuticals Business Overview
- 4.6.3 Validus Pharmaceuticals Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Validus Pharmaceuticals Potassium-Sparing Diuretic Product Portfolio
- 4.6.5 Validus Pharmaceuticals Recent Developments
- 4.7 CMP Pharma
- 4.7.1 CMP Pharma Company Information
- 4.7.2 CMP Pharma Business Overview
- 4.7.3 CMP Pharma Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CMP Pharma Potassium-Sparing Diuretic Product Portfolio
- 4.7.5 CMP Pharma Recent Developments
- 4.8 Centaur Pharmaceuticals
- 4.8.1 Centaur Pharmaceuticals Company Information
- 4.8.2 Centaur Pharmaceuticals Business Overview
- 4.8.3 Centaur Pharmaceuticals Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Centaur Pharmaceuticals Potassium-Sparing Diuretic Product Portfolio
- 4.8.5 Centaur Pharmaceuticals Recent Developments
- 4.9 Boehringer Ingelheim
- 4.9.1 Boehringer Ingelheim Company Information
- 4.9.2 Boehringer Ingelheim Business Overview
- 4.9.3 Boehringer Ingelheim Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boehringer Ingelheim Potassium-Sparing Diuretic Product Portfolio
- 4.9.5 Boehringer Ingelheim Recent Developments
- 4.10 Amneal Pharmaceuticals
- 4.10.1 Amneal Pharmaceuticals Company Information
- 4.10.2 Amneal Pharmaceuticals Business Overview
- 4.10.3 Amneal Pharmaceuticals Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Amneal Pharmaceuticals Potassium-Sparing Diuretic Product Portfolio
- 4.10.5 Amneal Pharmaceuticals Recent Developments
- 4.11 Accord Healthcare
- 4.11.1 Accord Healthcare Company Information
- 4.11.2 Accord Healthcare Business Overview
- 4.11.3 Accord Healthcare Potassium-Sparing Diuretic Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Accord Healthcare Potassium-Sparing Diuretic Product Portfolio
- 4.11.5 Accord Healthcare Recent Developments
5 Global Potassium-Sparing Diuretic Market Scenario by Region
- 5.1 Global Potassium-Sparing Diuretic Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Potassium-Sparing Diuretic Sales by Region: 2021-2032
- 5.2.1 Global Potassium-Sparing Diuretic Sales by Region: 2021-2026
- 5.2.2 Global Potassium-Sparing Diuretic Sales by Region: 2027-2032
- 5.3 Global Potassium-Sparing Diuretic Revenue by Region: 2021-2032
- 5.3.1 Global Potassium-Sparing Diuretic Revenue by Region: 2021-2026
- 5.3.2 Global Potassium-Sparing Diuretic Revenue by Region: 2027-2032
- 5.4 North America Potassium-Sparing Diuretic Market Facts & Figures by Country
- 5.4.1 North America Potassium-Sparing Diuretic Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Potassium-Sparing Diuretic Sales by Country (2021-2032)
- 5.4.3 North America Potassium-Sparing Diuretic Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Potassium-Sparing Diuretic Market Facts & Figures by Country
- 5.5.1 Europe Potassium-Sparing Diuretic Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Potassium-Sparing Diuretic Sales by Country (2021-2032)
- 5.5.3 Europe Potassium-Sparing Diuretic Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Potassium-Sparing Diuretic Market Facts & Figures by Country
- 5.6.1 Asia Pacific Potassium-Sparing Diuretic Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Potassium-Sparing Diuretic Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Potassium-Sparing Diuretic Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Potassium-Sparing Diuretic Market Facts & Figures by Country
- 5.7.1 South America Potassium-Sparing Diuretic Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Potassium-Sparing Diuretic Sales by Country (2021-2032)
- 5.7.3 South America Potassium-Sparing Diuretic Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Potassium-Sparing Diuretic Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Potassium-Sparing Diuretic Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Potassium-Sparing Diuretic Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Potassium-Sparing Diuretic Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Potassium-Sparing Diuretic Sales by Type (2021-2032)
- 6.1.1 Global Potassium-Sparing Diuretic Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Potassium-Sparing Diuretic Sales Market Share by Type (2021-2032)
- 6.2 Global Potassium-Sparing Diuretic Revenue by Type (2021-2032)
- 6.2.1 Global Potassium-Sparing Diuretic Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Potassium-Sparing Diuretic Revenue Market Share by Type (2021-2032)
- 6.3 Global Potassium-Sparing Diuretic Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Potassium-Sparing Diuretic Sales by Application (2021-2032)
- 7.1.1 Global Potassium-Sparing Diuretic Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Potassium-Sparing Diuretic Sales Market Share by Application (2021-2032)
- 7.2 Global Potassium-Sparing Diuretic Revenue by Application (2021-2032)
- 7.2.1 Global Potassium-Sparing Diuretic Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Potassium-Sparing Diuretic Revenue Market Share by Application (2021-2032)
- 7.3 Global Potassium-Sparing Diuretic Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Potassium-Sparing Diuretic Value Chain Analysis
- 8.1.1 Potassium-Sparing Diuretic Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Potassium-Sparing Diuretic Production Mode & Process
- 8.2 Potassium-Sparing Diuretic Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Potassium-Sparing Diuretic Distributors
- 8.2.3 Potassium-Sparing Diuretic Customers
9 Global Potassium-Sparing Diuretic Analyzing Market Dynamics
- 9.1 Potassium-Sparing Diuretic Industry Trends
- 9.2 Potassium-Sparing Diuretic Industry Drivers
- 9.3 Potassium-Sparing Diuretic Industry Opportunities and Challenges
- 9.4 Potassium-Sparing Diuretic Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst